NumFin

OPKO Health, Inc.

Sümbol: OPK

NASDAQ

1.3

USD

Turuhind täna

  • -5.1733

    P/E suhe

  • -0.0609

    PEG suhe

  • 906.09M

    MRK Cap

  • 0.00%

    DIV tootlus

OPKO Health, Inc. (OPK) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete OPKO Health, Inc. (OPK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 343.78 M, mis on 0.958 % gowth. Kogu perioodi keskmine brutokasum on 109.403 M, mis on 1.231 %. Keskmine brutokasumi suhtarv on 0.340 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.424 %, mis on võrdne -13.448 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes OPKO Health, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.072. Käibevara valdkonnas on OPK aruandlusvaluutas 309.476. Märkimisväärne osa neist varadest, täpsemalt 95.881, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.374%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 16.082, kui neid on, aruandlusvaluutas. See näitab erinevust -42.671% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 222.034 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.530%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 1389.219 aruandlusvaluutas. Selle aspekti aastane muutus on -0.110%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 130.2, varude hind on 65.7 ja firmaväärtus 598.26, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 935.28. Kontovõlad ja lühiajalised võlad on vastavalt 69.68 ja 43.12. Koguvõlg on 326.56, netovõlg on 230.68. Muud lühiajalised kohustused moodustavad 85.88, mis lisandub kohustuste kogusummale 622.48. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

453.3995.9153.2134.7
72.2
85.5
96.5
91.5
168.7
193.6
96.9
185.8
27.4
71.5
18
42.7
6.7
23.4
8.6
8.9
9.9
10.1
16.2
15
35.4
3.2
6.8
1.8
2.9
5.4

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
10
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

597.23130.2148.6265.6
302.3
157.7
162
187.1
249.5
208.9
23.1
31.4
23.5
12.5
14
8.8
1.1
1.9
0
-0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

283.8265.774.186.5
132.3
53.4
42.3
49.3
47.2
39.7
16.6
18.1
22.3
13.3
16.4
10.5
4.1
2.2
0
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

539.1117.7241.3373.3
451
238.5
221.2
9.2
314.9
260.5
46
5.7
4.8
2.2
2.8
1.9
0.3
0.3
0.2
0.1
0.2
1.2
1.1
10.7
0.5
0.1
0.1
0.1
0
0

balance-sheet.row.total-current-assets

1506.87309.5394.5823
523.2
324
317.7
348.9
483.6
454.1
142.9
242.7
78.7
99.6
57.4
63.8
13.5
29.2
8.8
9
10.1
11.3
17.3
26.3
35.9
3.3
6.9
1.9
2.9
5.4

balance-sheet.row.property-plant-equipment-net

497.88143.5121.6124
178.3
166.5
144.7
146.6
122.8
131.8
16.4
17
15.7
5.4
2.6
0.6
0.7
0.4
0
0
0
0
0.2
1
0.5
0.3
0.1
0.1
0.1
0.1

balance-sheet.row.goodwill

2387.47598.3595.9520.6
680.6
671.9
700.2
717.1
704.6
743.3
224.3
226.4
80.5
39.8
5.9
5.4
1.1
1.7
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

3474.51935.3790.91110.8
1270.8
1262.1
1335.8
1331.2
1349.3
1535.6
1017.4
867.9
95.8
76.7
6.8
12.7
6.3
8.2
0
0
0
0
0
0.1
0.7
0.8
0.7
0.8
0.9
0.9

balance-sheet.row.goodwill-and-intangible-assets

4690.011533.5790.91110.8
1270.8
1262.1
1335.8
2048.3
1349.3
1535.6
1017.4
1094.2
176.2
116.5
12.6
18.1
7.4
9.9
0
0
0
0
0
0.1
0.7
0.8
0.7
0.8
0.9
0.9

balance-sheet.row.long-term-investments

104.4416.128.110.7
15.7
20.7
31.2
40.6
41.1
34.7
22.5
30.7
15.6
6.7
5.1
4.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

52.81950-134.7
-194
-187.2
-175.9
0
-164
-166.5
-38.9
0
0.8
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

1544.91-185.9832.2465.9
679.1
723.2
797.6
5.6
933.7
809.9
107.4
6.9
2.8
1.3
0.1
0
0.2
0
0
0
0
0
0
0.3
0.3
0.1
0
0
0
0.1

balance-sheet.row.total-non-current-assets

6890.031702.21772.81576.7
1949.9
1985.3
2133.4
2241.1
2283
2345.5
1124.8
1148.8
211.2
129.9
20.5
23.6
8.3
10.4
0
0
0
0
0.3
1.4
1.5
1.1
0.8
0.9
1
1.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

8396.92011.72167.32399.7
2473.1
2309.3
2451.1
2590
2766.6
2799.6
1267.7
1391.5
289.8
229.5
77.8
87.4
21.8
39.6
8.8
9
10.1
11.3
17.5
27.6
37.4
4.5
7.7
2.8
3.9
6.5

balance-sheet.row.account-payables

304.8569.76782
100.9
62.5
47.4
74.3
53.4
72.5
8.7
13.4
10.2
4.9
6.5
4.8
2.2
3.3
0.7
0.3
0.2
1
1.2
1.2
0.6
0.7
0.5
0.5
0.3
0.2

balance-sheet.row.short-term-debt

163.1443.13.128.6
36.2
24.4
40.7
15.3
15
16.8
13.5
12.6
17.5
8.8
14.7
4.3
0.1
2.5
0
0
0
0
0.1
0
0.1
0.1
0.2
0.1
0
0

balance-sheet.row.tax-payables

5.11.400
0
0
3.2
4.6
4.4
7.6
0.1
0.7
1.6
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

899.53222210.4187.9
222
211.2
31.6
142.7
43.7
49.4
131.5
215.2
5.2
0
0
15.3
11.9
11.7
0
0
0
0
0.1
0.2
0
0
0
0
0
0

Deferred Revenue Non Current

0.4200.10.2
0.6
2.6
27.6
95.5
89
162.6
-167.2
0
3.9
0
0
-3.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

527.52---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

329.1185.9143.4190.9
222.7
143
105.2
165.5
121.5
92.3
56.7
58.2
23.1
0.2
3.1
3.9
5.4
3.9
0
0
0
0
0
0.1
0.1
0.2
0
0
0.1
1.3

balance-sheet.row.total-non-current-liabilities

1626.43422.4392.2412.8
426
445.4
403
434.3
411.5
567.9
348.8
426.7
34.2
49.8
27.2
16.7
13.7
13.1
0
0
0
0
0.1
0.2
0.8
0.9
0.9
1.1
1.2
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

191.5161.449.549.9
44
46.5
8.9
11.2
10.2
14.7
0
0
0
0
0
0
1.8
1.4
0
0
0
0
0.1
0.2
0
0
0
0
0
0

balance-sheet.row.total-liab

2475.93622.5605.7714.6
801.5
694.5
659.8
746.3
674.8
819.8
431.9
518.5
86.5
68.6
54.8
29.7
21.4
22.8
0.7
0.3
0.2
1
1.4
1.5
1.6
1.9
1.6
1.7
1.6
1.5

balance-sheet.row.preferred-stock

0.03000
0
0
0.1
0
0
0
0
1391.5
24.4
24.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

31.277.87.86.9
6.7
6.7
5.9
5.6
5.6
5.5
4.3
4.1
3.1
3
2.6
2.5
2
1.8
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0
0
0
0

balance-sheet.row.retained-earnings

-7659.11-2011.8-1822.9-1512
-1481.8
-1511.1
-1197.1
-1048.9
-730
-704.9
-674.8
-503.2
-388.8
-359.7
-358.4
-339.2
-309.1
-269.3
-57
-56.4
-56.2
-54.3
-48.5
-38.1
-29.4
-22.2
-17.8
-15.1
-11.9
-9

balance-sheet.row.accumulated-other-comprehensive-income-loss

-159.08-38-43.3-30.5
-4.2
-22.1
-20.1
-0.5
-27
-22.5
-12.4
3.4
7.4
0.9
2.9
1.3
-0.2
-0.1
0
-0.1
0.8
-0.3
-0.3
-0.4
-0.1
-0.1
-0.3
-0.2
-0.2
-0.1

balance-sheet.row.other-total-stockholders-equity

13707.853431.234203220.7
3151
3141.2
3002.5
2887.5
2843.2
2701.7
1518.7
-19.5
557.7
492.3
375.9
393.1
307.7
284.4
64.9
65
65
64.7
64.7
64.5
65.1
24.8
24.2
16.4
14.4
14.1

balance-sheet.row.total-stockholders-equity

5920.971389.21561.61685.1
1671.6
1614.8
1791.3
1843.6
2091.8
1979.8
835.8
876.4
203.8
160.9
23.1
57.7
0.4
16.8
8.1
8.7
9.8
10.3
16.1
26.1
35.8
2.6
6.1
1.1
2.3
5

balance-sheet.row.total-liabilities-and-stockholders-equity

8396.92011.72167.32399.7
2473.1
2309.3
2451.1
2590
2766.6
2799.6
1267.7
1391.5
289.8
229.5
77.8
87.4
21.8
39.6
8.8
9
10.1
11.3
17.5
27.6
37.4
4.5
7.7
2.8
3.9
6.5

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
-6.4
-3.4
-0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

5920.971389.21561.61685.1
1671.6
1614.8
1791.3
1843.6
2091.8
1979.8
829.4
873
203.3
160.9
23.1
57.7
0.4
16.8
8.1
8.7
9.8
10.3
16.1
26.1
35.8
2.6
6.1
1.1
2.3
5

balance-sheet.row.total-liabilities-and-total-equity

8396.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

104.4416.128.110.7
15.7
20.7
31.2
40.6
41.1
34.7
22.5
30.7
15.6
6.7
5.1
4.4
0
0
0
0
1.1
0
10
0
0
0
0
0
0
0

balance-sheet.row.total-debt

1046.83326.6213.5187.9
222
211.2
31.6
158
43.7
49.4
131.5
227.7
22.7
8.8
14.7
19.7
12
14.2
0
0
0
0
0.2
0.2
0.1
0.1
0.2
0.1
0
0

balance-sheet.row.net-debt

593.45230.760.353.2
149.8
125.7
-64.9
66.5
-125
-144.2
34.6
41.9
-4.7
-62.8
-3.3
-23
5.3
-9.1
-8.6
-8.9
-8.7
-10.1
-6
-14.8
-35.3
-3.1
-6.6
-1.7
-2.9
-5.4

Rahavoogude aruanne

OPKO Health, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.629 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.090 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -18198000.000. See on -1.200 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 105.3, 0, -11.03, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte 0 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -11.3, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

cash-flows.row.net-income

-188.89-188.9-328.4-30.1
30.6
-314.9
-153
-305.3
-25.1
-31.4
-174.6
-117.3
-29.6
-5.2
6.3
-30.1
-39.8
-268.4
-0.6
-0.2
-1.9
-5.8
-10.4
-8.8
-7.2
-3.9
-2.7
-3.3
-2.9
-2.7

cash-flows.row.depreciation-and-amortization

105.3105.3108.778.7
85.4
93.8
97.3
102.1
96.6
42.2
14.9
15.2
10.2
3.8
2.2
2.4
1.8
0.2
0
0
0
0.1
0.5
0.3
0.3
0.2
0.1
0.1
0.1
0.7

cash-flows.row.deferred-income-tax

0.150.1-74.410.2
15.6
4.3
-35.1
16.1
-66.3
-123.5
1
0.6
-10
-19.4
-1.2
1.6
-6.6
-6.7
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

11.4111.418.513.6
8.9
13.4
21.8
28.3
42.7
26.1
14.8
11
5.1
7
6.5
4.6
6.7
7.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

21.821.842.7-20.5
-97.6
-68.8
-58.1
48.4
-43.2
180.1
-3.8
1.2
-4.6
-1.3
-13.1
-4.1
-0.2
-0.8
0.3
0.1
0.2
-0.3
0
0.3
-0.5
0.3
0.1
0.1
0.1
3.9

cash-flows.row.account-receivables

3.413.4128.65.2
-150.4
7.4
20.4
58
-25.6
-29.4
-3.9
0.8
0.8
-1.7
-2.9
-1.3
0.6
-0.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

15.215.213.730.7
-77.6
-12.1
4.6
-3.5
-6.6
-5.9
-1.8
1.9
-5.8
2.2
-8.2
-0.9
-2.1
-0.3
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

2.832.8-9.4-10.8
37.2
15.6
-26.1
20.2
-19.8
-18.1
-3.9
1.8
1.2
-1.8
1.5
-1
-1.2
-0.6
0.4
0
-0.2
-0.3
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0.360.4-90.2-45.6
93.3
-79.7
-57
-26.3
8.9
233.5
5.7
-3.3
-0.8
0
-3.6
-0.9
2.5
0.7
-0.1
0.1
0.4
0
0
0.3
-0.5
0.3
0.1
0.1
0.1
0

cash-flows.row.other-non-cash-items

22.0422137.8-13.5
-3.5
99.7
18.1
18.3
27.4
70.6
57.4
31.2
3.5
-3.4
-19.7
2.4
8.8
251.4
0
-0.9
0.1
0.2
1
0.2
2.4
0.2
0.1
0.2
0.2
-3.9

cash-flows.row.net-cash-provided-by-operating-activities

-28.2000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-16.27-16.3-24.6-32.2
-33.7
-12.7
-27.9
-46.5
-23.5
-15.8
-4.7
-4
-1.5
-2
-0.8
-0.2
-0.4
-0.5
0
0
0
0
0
-0.5
-0.4
-0.3
-0.1
0
-0.1
0

cash-flows.row.acquisitions-net

-2.612.7-1.8-6
0.2
-1.2
-1
-9.6
1.5
-83.4
-2.3
3.1
-22.5
-28.2
-1.3
-17.6
0
2.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-5032.2
-0.2
-1.2
27.9
46.5
-15.6
0
4.7
-50
-25.8
-102.2
-15.6
-14.8
0
-5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0.360.4115.48.1
15.1
1.2
1.5
2.2
15.6
0
1.3
80.6
25
100.2
15
10
0
5
0
1.1
10
10
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0.840233.9
0.2
0.7
-26.6
-39.3
1.4
0
-4.7
0.6
0
17.3
0
0
0
-5
0
0
0
0
0.1
-10.1
-0.2
-0.1
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

-18.2-18.29135.9
-18.3
-13.3
-26.1
-46.7
-20.7
-99.2
-5.7
30.3
-24.8
-14.8
-2.8
-22.6
-0.3
-2.7
0
1.1
10
10
0.1
-10.5
-0.6
-0.3
-0.1
0
-0.1
0

cash-flows.row.debt-repayment

-526.35-11-1035.8-1696
-1143.7
-388.1
-34.7
-33.5
-66.2
-254.4
-28.4
-39
-32.8
-20.1
-6.3
-3.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

00221.71.1
0.8
76.1
92.5
0
4.9
0
0
0
0
104.8
0
51
15.4
36.4
0
0
0.2
0
0
0
40
0.1
2.6
1.9
0
9.4

cash-flows.row.common-stock-repurchased

-0.27-0.300
0
0
0
0
0
0
0
0
0
-9.6
0
0
0
0
0
0
0
0
0
-1.3
-2
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
-3
0
-4.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

515.32-11.3837.11684.5
1107.9
487.3
83.1
94.6
26.1
287.4
35.6
228.2
38.8
16.5
3.5
34.2
-2.5
6.5
0
0
0
-0.2
-0.1
-0.6
-0.1
-0.1
4.8
0
0
-2.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-11.3-11.323-10.4
-35.1
175.2
140.9
61
-35.2
33
7.3
186.2
6
86.9
-2.8
81.9
12.9
42.9
0
0
0.2
-0.2
-0.1
-1.9
37.8
-0.1
7.4
1.9
0
7.1

cash-flows.row.effect-of-forex-changes-on-cash

0.390.4-0.3-1.4
0.7
-0.5
-0.7
0.5
-1
-1.1
-0.1
0.1
0
-0.1
0
0
0
0
0
0
-10
0
0
0
0
0
2.5
0
0
0

cash-flows.row.net-change-in-cash

-57.31-57.318.562.5
-13.2
-11
5
-77.2
-24.9
96.7
-88.9
158.4
-44.2
53.5
-24.6
36
-16.7
23.3
-0.3
0.2
-1.4
4
-8.8
-20.4
32.2
-3.6
7.4
-1
-2.6
5.1

cash-flows.row.cash-at-end-of-period

453.4495.9153.2134.7
72.2
85.5
96.5
91.5
168.7
193.6
96.9
185.8
27.4
71.5
18
42.7
6.7
23.4
8.6
8.9
8.7
10.1
6.2
15
35.4
3.2
9.2
1.9
2.8
5.5

cash-flows.row.cash-at-beginning-of-period

510.75153.2134.772.2
85.5
96.5
91.5
168.7
193.6
96.9
185.8
27.4
71.5
18
42.7
6.7
23.4
0.1
8.9
8.7
10.1
6.1
15
35.4
3.2
6.8
1.8
2.9
5.4
0.4

cash-flows.row.operating-cash-flow

-28.2-28.2-95.238.3
39.5
-172.5
-109.1
-92.1
32
164
-90.4
-58.2
-25.4
-18.5
-19.1
-23.3
-29.3
-16.9
-0.3
-0.9
-1.6
-5.8
-8.8
-8
-5
-3.2
-2.4
-2.9
-2.5
-2

cash-flows.row.capital-expenditure

-16.27-16.3-24.6-32.2
-33.7
-12.7
-27.9
-46.5
-23.5
-15.8
-4.7
-4
-1.5
-2
-0.8
-0.2
-0.4
-0.5
0
0
0
0
0
-0.5
-0.4
-0.3
-0.1
0
-0.1
0

cash-flows.row.free-cash-flow

-44.47-44.5-119.86.2
5.8
-185.3
-137
-138.6
8.5
148.2
-95.1
-62.2
-26.9
-20.5
-19.9
-23.5
-29.7
-17.4
-0.3
-0.9
-1.6
-5.8
-8.8
-8.5
-5.4
-3.5
-2.5
-2.9
-2.6
-2

Kasumiaruande rida

OPKO Health, Inc. tulud muutusid võrreldes eelmise perioodiga -0.140%. OPK brutokasum on teatatud 232.09. Ettevõtte tegevuskulud on 390.15, mille muutus võrreldes eelmise aastaga on -26.993%. Kulud amortisatsioonikulud on 105.3, mis on 0.551% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 390.15, mis näitab -26.993% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.358% kasvu võrreldes eelmise aastaga. Tegevustulu on -158.06, mis näitab -0.358% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.424%. Eelmise aasta puhaskasum oli -188.86.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

863.52863.51004.21774.7
1435.4
901.9
990.3
966
1221.7
491.7
91.1
96.5
47
28
28.5
13.1
9.4
0.8
0
0
0
0
0.6
1.3
0.9
1.4
1.2
0.1
0.1
0.1

income-statement-row.row.cost-of-revenue

566.84631.47161193.2
894.4
572.5
604.6
620.1
611.5
590.2
236.9
48.9
27.9
17.2
13.5
9.6
8.6
0.8
0
0
0
0
0
0
-0.3
-0.2
-0.1
-0.1
-0.1
0.5

income-statement-row.row.gross-profit

296.68232.1288.2581.5
541
329.4
385.7
345.9
610.2
-98.5
-145.8
47.7
19.2
10.7
15
3.6
0.9
0
0
0
0
0
0.6
1.3
1.2
1.6
1.3
0.2
0.2
-0.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

89.56---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-14.87-1787.850.3
56.4
64.8
-6
10.5
-0.2
-39.5
-25.2
25.3
1.3
3.4
3.6
3.2
1.7
0.8
0
0
0
0
0
0
0.3
0.2
0.1
0.1
0.1
0.7

income-statement-row.row.operating-expenses

454.79390.2534.4596
487.3
526
551.9
625.7
666.5
349.9
152.4
120.4
55.6
33.9
26.1
29.6
38
24.1
1.1
1.4
2.1
3.7
9.6
11.9
9.8
5.7
4.3
3.5
3.2
1.8

income-statement-row.row.cost-and-expenses

1021.631021.61250.41789.2
1381.7
1098.5
1156.5
1245.9
1278
590.2
236.9
169.2
83.5
51.2
39.6
39.2
46.6
24.9
1.1
1.4
2.1
3.7
9.6
11.9
9.5
5.5
4.2
3.4
3.1
2.3

income-statement-row.row.interest-income

3.98420
0.2
1.7
1.2
0.6
0.5
0.3
0.8
0.4
0.2
0.3
0
0
0
0
0.5
0.2
-0.1
0.2
0
0
1.5
0
0
0
0
0

income-statement-row.row.interest-expense

-0.0413.512.118.9
21.9
21.5
11.9
6.6
7.4
8.4
12.3
13.8
1.4
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-24.04-26.3-145.333.7
-9
-108.3
-11
13.9
-17.2
-39.5
-25.2
-18.1
0.5
-0.3
-0.8
-4
-1.4
-245.2
0.5
1.1
0.1
-2.2
-2
0.3
1.5
0
0.3
0.1
0.2
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-14.87-1787.850.3
56.4
64.8
-6
10.5
-0.2
-39.5
-25.2
25.3
1.3
3.4
3.6
3.2
1.7
0.8
0
0
0
0
0
0
0.3
0.2
0.1
0.1
0.1
0.7

income-statement-row.row.total-operating-expenses

-24.04-26.3-145.333.7
-9
-108.3
-11
13.9
-17.2
-39.5
-25.2
-18.1
0.5
-0.3
-0.8
-4
-1.4
-245.2
0.5
1.1
0.1
-2.2
-2
0.3
1.5
0
0.3
0.1
0.2
0

income-statement-row.row.interest-expense

-0.0413.512.118.9
21.9
21.5
11.9
6.6
7.4
8.4
12.3
13.8
1.4
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

95.63105.367.950.3
48.4
142.3
67.9
102.1
64.4
42.2
14.9
15.2
10.2
3.8
2.2
2.4
1.8
0.2
0
0
0
0.1
0.5
0.3
0.3
0.2
0.1
0.1
0.1
0.7

income-statement-row.row.ebitda-caps

-83.92---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-156.97-158.1-246.2-47.7
57.7
-196.6
-171.2
-276.4
-73.3
-98.5
-145.8
-79.6
-37.3
-23.2
-11.1
-28
-38.6
-267.9
-1.1
-1.4
-2.1
-3.7
-9
-10.5
-8.6
-4.2
-3
-3.3
-3
-2.2

income-statement-row.row.income-before-tax

-184.35-184.3-391.5-14
48.7
-304.9
-177.2
-271.9
-73.5
-138
-171
-104.2
-37.2
-24.2
-12
-30.1
-39.9
-267.9
-0.6
-0.2
-1.9
-5.8
-10.4
-8.9
-7.1
0
-2.7
-3.2
-2.8
0

income-statement-row.row.income-tax-expense

4.454.4-63.515.5
17.6
7.1
-38.7
18.9
-56.1
-113.7
0
1.7
-9.6
-19.4
0
-0.3
-0.1
-0.1
0.2
0.2
0.2
0.2
1.3
-0.1
0.1
0.2
-0.3
0
-0.1
0.5

income-statement-row.row.net-income

-188.85-188.9-328-29.5
30.6
-312
-153
-305.3
-25.1
-30
-171.7
-114.4
-29
-1.3
-18.9
-30.1
-39.8
-268.4
-0.6
-0.2
-1.9
-5.8
-10.4
-8.8
-7.2
-4.4
-2.7
-3.3
-2.9
-2.7
Sarnased aktsiad
Sind võib huvitada ka:
RVTY
Revvity, Inc..
100.61 USD
NYSE
GTG.AX
Genetic Technologies Limited.
0.12 AUD
ASX
LAB
Standard BioTools Inc..
2.51 USD
NASDAQ
IDXX
IDEXX Laboratories, Inc..
480.6 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.33 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.12 AUD
ASX
DGX
Quest Diagnostics Incorporated.
137.38 USD
NYSE
QIA.DE
Qiagen N.V..
39.94 EUR
XETRA
300685.SZ
Amoy Diagnostics Co., Ltd..
20.57 CNY
SHZ
603259.SS
WuXi AppTec Co., Ltd..
43.67 CNY
SHH
2395.T
Shin Nippon Biomedical Laboratories, Ltd..
1535 JPY
JPX

Korduma kippuv küsimus

Mis on OPKO Health, Inc. (OPK) koguvara?

OPKO Health, Inc. (OPK) koguvara on 2011698000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 360500000.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.344.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -0.059.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.219.

Mis on ettevõtte kogutulu?

Kogutulu on -0.182.

Mis on OPKO Health, Inc. (OPK) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -188863000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 326564000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 390152000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 95881000.000.